Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

by GBD 2015 Tobacco Collaborators
The Lancet, Vol. 389, No. 10082, pp.1885–1906, 13 May 2017

22 pp. 19.7 MB(!)
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(17)30819-X.pdf

The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and national progress toward achieving smoking-related targets can be assessed.

(Visited 15 times, 1 visits today)
This entry was posted in General, Global Health, Non-communicable Diseases. Bookmark the permalink.